Trust Company’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.4K | Hold |
39
| – | – | ﹤0.01% | 285 |
|
|
2025
Q1 | $18.9K | Hold |
39
| – | – | ﹤0.01% | 293 |
|
|
2024
Q4 | $15.7K | Hold |
39
| – | – | ﹤0.01% | 297 |
|
|
2024
Q3 | $18.1K | Sell |
39
-6
| -13% | -$2.79K | ﹤0.01% | 263 |
|
|
2024
Q2 | $21.1K | Hold |
45
| – | – | ﹤0.01% | 247 |
|
|
2024
Q1 | $18.8K | Sell |
45
-836
| -95% | -$349K | ﹤0.01% | 254 |
|
|
2023
Q4 | $358K | Sell |
881
-56
| -6% | -$22.8K | 0.05% | 99 |
|
|
2023
Q3 | $326K | Sell |
937
-419
| -31% | -$146K | 0.05% | 101 |
|
|
2023
Q2 | $477K | Sell |
1,356
-103
| -7% | -$36.2K | 0.07% | 86 |
|
|
2023
Q1 | $460K | Buy |
1,459
+70
| +5% | +$22.1K | 0.07% | 96 |
|
|
2022
Q4 | $401K | Sell |
1,389
-107
| -7% | -$30.9K | 0.07% | 106 |
|
|
2022
Q3 | $433K | Sell |
1,496
-392
| -21% | -$113K | 0.09% | 87 |
|
|
2022
Q2 | $532K | Buy |
+1,888
| New | +$532K | 0.11% | 81 |
|
|
2015
Q3 | – | Sell |
-150
| Closed | -$19K | – | 392 |
|
|
2015
Q2 | $19K | Buy |
+150
| New | +$19K | 0.01% | 254 |
|